In order to further improve the innovation system, WEGO has established a national-recognized enterprise technology center, a national engineering laboratory of implants, a national innovation pilot enterprise, an academician workstation, a postdoctoral workstation, Shandong High-performance Medical Device Research Center, Shandong Medical Device Technology Innovation Center, a provincial engineering technology research center, Taishan Scholar Laboratory and other innovation platforms, accelerates the construction of three major platforms including WEGO Research Institute, National Innovation Center and Beijing & Changchun R & D Center, and carries out industry-university-research cooperation with more than 30 well-known universities and research institutes such as the Chinese Academy of Sciences, the Chinese Academy of Engineering, the Academy of Military Medical Sciences, Chinese PLA General Hospital, Harbin Industrial University and Tianjin University, with over 30 research institutions established. WEGO has more than 1,100 patents, including more than 400 invention patents. It possesses more than 900 products with independent intellectual property right, among them, high-tech products and high value-added products account for more than 80%. More than 100 products such as orthopaedic materials series, blood purification series, intra-cardiac consumables series, artificial liver, automatic chemiluminescence analyzer, colour ultrasonic diagnosis, DR, pre-filled syringes, membrane oxygenator and protein A immuno-adsorption column have broken foreign monopolies and become well-known international brands. 30 products have been included in the National Torch Plan, "863 Program" and other national projects. WEGO has won four state technological invention awards and state science and technology awards (polyolefin materials, infusion and intervention technique, cardiac drug-eluting stent technology, new technology for treatment of severe chest trauma in battlefield), with its minimally invasive surgery robot winning the gold award of China Excellent Industrial Design.

WEGO has passed ISO 9000 international quality system certification, ISO 13485 quality system certification, CE certification and GMP certification, and gained FDA recognition by upholding scientific management and improving the quality management system. Advanced production equipment are introduced from abroad to enhance technological transformation, increase the technological level, and promote product upgrading. WEGO's products sell well in China, and are sold to multiple countries and regions in the world such as America, Europe, Asia and Africa. The domestic market share of high-end infusion sets and syringes, blood transfusion equipment and consumables, pharmaceutical packaging materials and other products is about 70%. The domestic market share of orthopaedic material series, blood purification series, intra-cardiac consumables and other series is about 30%.

WEGO gives strong support to social welfare and charity, and has carried out activities such as WEGO Light Action, WEGO Loving Care Project, WEGO Life Relay Project, with a total donation of more than RMB 600 million. WEGO Light Action has provided cataract surgery for free for over 20,000 patients since its implementation in 2004; WEGO Loving Care Project has helped more than 2,000 teenagers with idiopathic scoliosis. WEGO donated RMB 10 million to Weihai One Day Donation of Love, during the 2020’s outbreak, WEGO donated money and goods more than 50 million.

WEGO will always adhere to the spirit "Innovative and Pragmatic", uphold the mission of “Your Health, We Care”, establish the core values of conscience, integrity and loyalty, and insist on the development strategy of “One Center, Three Adjustments”, to apply itself to building a global company and world-leading enterprise and joining the ranks of strong international medical device enterprises, realizing the vision of "to be the strongest in China, best in-class globally, the most respected innovative medical devices and pharmaceutical company."